Promoters of laxmi dental have confirmed that no encumbrance was created on the equity shares held by them during the financial year ended March 31, 2026. The declaration, submitted by Promoter Dharmesh Bhupendra Dattani on behalf of all promoters and promoter groups, ensures compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The disclosure confirms that neither the promoters nor the promoter group members pledged or created any charge, directly or indirectly, on their shareholding throughout the specified financial period. This regulatory filing provides transparency regarding the holding status of the company's key stakeholders.

The declaration covers six individuals identified as promoters and promoter group members. The list includes Mr. Rajesh Vrajlal Khakhar, Mr. Sameer Kamlesh Merchant, and Mr. Dharmesh Bhupendra Dattani as promoters. The promoter group comprises Mrs. Jigna Rajesh Khakkar, Mr. Kunal Kamlesh Marchant, and Mr. Hasmukh Vrajlal Khakkar.

Promoters and Promoter Groups

The document was addressed to the Audit Committee of Laxmi Dental Limited and the stock exchanges, BSE Limited and National Stock Exchange of India Limited. The confirmation was signed and submitted in Mumbai on April 06, 2026.

Laxmi Dental Limited has announced its audited consolidated financial results for the quarter and financial year ended March 31, 2026. The company recorded its highest-ever quarterly revenue of ₹739.5 Mn in Q4FY26, representing a growth of 21.9% year-on-year. Profit After Tax (PAT) for the quarter stood at ₹100.9 Mn, a significant increase of 136.1% compared to ₹42.7 Mn in the corresponding quarter of the previous year.

Financial Performance

EBITDA for the quarter stood at ₹135.0 Mn, an increase of 41.8% YoY, with an EBITDA margin of 18.3%. For the full financial year FY26, revenue grew by 16.2% YoY to ₹2,778.6 Mn, while PAT was ₹289.2 Mn. The company remains debt-free with a cash and bank balance including investments of around ₹99 crores.

Operational Highlights

Gross profit margins for Q4FY26 stood at 70.5%, showing a sequential improvement. Excluding scanner sales, the gross margins for the Core Dental Business remained steady at approximately 76.0%. The company noted that scanner sales, while low margin, are strategic and act as an enabler for future growth in the Dental Lab and Aligner business. The company sold 211 scanners in Q4FY26 and 1,009 units in FY26.

Margins during the quarter were affected by a half-quarter impact of 74 basis points on EBITDA due to higher US tariffs. ESOP expenses, which are non-cash in nature, amounted to ₹1.3 Mn in Q4FY26 compared to ₹18.3 Mn in Q4FY25. Additionally, a tax benefit of ₹13 Mn was recorded in Q4FY26 related to a one-time exceptional item on gratuity expense recognized in Q3FY26.

For the full year FY26, margins were impacted by multiple one-offs, including a 72 bps US Tariff impact and a one-time expense of ₹57.8 Mn due to changes in the labour code. The company also recognized a positive impact of ₹32.3 Mn from deferred tax credit as its US subsidiary became profitable in FY26.

Segment Performance

The Dental Laboratory business reported its highest-ever quarterly performance, delivering a robust 27% YoY growth driven by a recovery in domestic business and international operations. The Aligner Solutions business reported revenue of ₹18 Cr during the quarter. Within this segment, Bizdent, the clear aligner business, recorded an 11% YoY growth, while Vedia, the aligner raw material business, reported a revenue of ₹7 Cr.

Management representatives including Mr. Rajesh Khakhar, Mr. Sameer Merchant, and Mr. Dharmesh Dattani participated in the earnings call organized on May 22, 2026.